| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | — | -23.6% |
| Cost of Revenue | $1.2M | — | -24.4% |
| Gross Profit | $396K | — | -21.0% |
| R&D Expense | $143K | — | +25.7% |
| SG&A Expense | $2.2M | — | +31.4% |
| Operating Income | -$1.8M | — | -54.3% |
| Pre-tax Income | -$1.8M | — | -53.0% |
| Income Tax | $26 | — | -31.6% |
| Net Income | -$1.8M | — | -53.0% |
| EPS (Basic) | -$0.17 | — | +54.1% |
| EPS (Diluted) | -$0.17 | — | +54.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.1M | +2.9% | +179.7% |
| Accounts Receivable | $616K | -14.3% | +4.0% |
| Inventory | $2.4M | -14.9% | -59.7% |
| Current Assets | $6.6M | -6.2% | -18.2% |
| Total Assets | $7.5M | -6.7% | -18.5% |
| Current Liabilities | $1.0M | +2.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | — | +8.2% |
| Investing Cash Flow | $3K | — | +0.0% |
| Financing Cash Flow | $1.2M | — | -31.4% |
| -80.9% |
| Long-term Debt | $190K | -3.8% | -14.5% |
| Total Liabilities | $1.5M | -3.6% | -75.5% |
| Stockholders' Equity | $6.0M | -7.4% | +89.3% |